the evolving role of maintenance therapy post-asct in mm
Published 4 years ago • 61 plays • Length 2:52Download video MP4
Download video MP3
Similar videos
-
1:22
maintenance therapy in mm: perspectives
-
2:40
the role of consolidation therapy in mm and updates from the emn02 trial
-
1:34
the evolving role of transplantation
-
5:36
the evolving role of imids
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
9:25
mgus diagnosis: a step-by-step approach
-
16:38
leukocyte abnormalities and disorders (an overview)
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
3:15
goal of therapy in al amyloidosis: what predicts the best outcome?
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:44
improving maintenance therapy in aml: exploring the role of idh inhibitors
-
1:12
insights into majestec-4: assessing the role of teclistamab as maintenance in patients with myeloma
-
2:26
lenalidomide as post-autosct maintenance therapy for multiple myeloma
-
3:02
the role of asparaginase in the treatment of all
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
4:12
insight-mm: real-world patterns of patient characteristics
-
1:10
latest developments in the treatment of emd in myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
5:25
how the aml treatment landscape is changing with the introduction of novel targeted agents
-
1:56
the efficacy of olutasidenib in patients with r/r idh-mutant aml
-
1:48
do all patients require maintenance therapy following allosct?